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electrodes.  Results: There was no complication related to 
the CCTA itself. Intraoperative CCTA entailed modification of 
the original trajectory based on the preoperative MRI in 27 
of 146 electrode implantations (18.5%). In 10 of them, a se-
vere vascular complication was adverted by intraoperative 
CCTA. The safety of this new approach was also confirmed 
by the analysis of postinterventional CT, which revealed a 
symptomatic hematoma caused by 1 single electrode out of 
the 1,310 implanted.  Conclusions: This study showed that 
intraoperative CCTA in addition to preoperative MRI is useful 
in guiding a safer SEEG electrode implantation. The combi-
nation of both imaging modalities essentially minimizes the 
risk of serious hemorrhagic complications. 
 © 2016 S. Karger AG, Basel 
 Introduction 
 Following the introduction of scalp electroencepha-
lography (EEG) recording by Berger  [1] in 1929, intracra-
nial recording started in the middle of the last century 
 [2–6] . First, intracranial electrodes for seizure localiza-
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 Abstract 
 Background: Stereotactic electroencephalography (SEEG) is 
an invasive diagnostic tool for localizing the epileptic zone 
in patients with medically refractory focal epilepsy. Despite 
technical and imaging advances in guiding the electrode 
placement, vascular injury is still one of its most serious com-
plications.  Object: To investigate the usefulness of intraop-
erative cerebral C-arm CT angiogram (CCTA) in avoiding in-
tracranial hemorrhagic complications during SEEG electrode 
implantation.  Methods: Trajectory data from 12 patients 
who underwent SEEG electrode implantation were studied 
in detail. This included an analysis of the implantation of 146 
SEEG electrodes, which were guided by intraoperative CCTA, 
as well as the standard planning based on preoperative con-
trast-enhanced MRI. In addition, a prospective analysis of 
SEEG hemorrhagic complications using the studied method-
ology was performed in a total of 87 patients receiving 1,310 
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tion were implanted freehandedly  [2, 7–9] . Later, this 
procedure was guided by the stereotactic technique  [10–
12] . In the 1960s Talairach and Bancaud  [13] developed 
the methodology and technique of stereotactic EEG 
(SEEG) for the evaluation of patients with medically re-
fractory partial epilepsy. Since then, SEEG has been a 
well-utilized procedure in a large number of patients with 
medically refractory partial epilepsy  [14, 15] .
 In terms of safety and morbidity, intracranial hemor-
rhagic events due to vascular injury during electrode im-
plantation are considered the most feared complication 
 [16–19] . In recent years, advances in structural and func-
tional neuroimaging techniques, such as CT and MRI, 
improved the safety, accuracy and efficacy of the SEEG 
implantation technique  [20–23] . Beyond the general 
well-known cortical anatomical landmarks, the patient’s 
individual vasculature is one of the most important ana-
tomical nuances to be recognized and understood in or-
der to avoid possible vascular injuries. While SEEG elec-
trode implantation has been guided by ventriculography 
and conventional cerebral angiography in the past, ad-
vanced imaging modalities, such as the angio-CT and an-
gio-MRI, are now used to guide SEEG electrode implan-
tation more precisely  [12, 22–24] . 
 Our group has been performing SEEG procedures 
since 2009, applying the C-arm CT angiogram (CCTA) 
during SEEG implantation. The role of cerebral angiog-
raphy and CCTA in preventing vascular injury during 
SEEG procedures has been unclear. The aim of this study 
was to investigate the utility of intraoperative cerebral 
CCTA during SEEG implantation in the diagnosis and 
treatment of refractory focal epilepsy.
 Methods 
 Part I: Accuracy 
 Twelve consecutive patients with the diagnosis of refractory fo-
cal epilepsy who were implanted with SEEG electrodes were pro-
spectively studied. In total, 146 electrodes were analyzed regarding 
the accuracy of implantation and complication rate. The study was 
approved by the Cleveland Clinic Institutional Review Board. 
 Patient Selection for SEEG 
 The indications for SEEG as well as the planning of implanta-
tion were individualized and previously discussed at our weekly 
patient management conference. On average, 15 electrodes were 
implanted per patient. The selection criteria for SEEG procedures 
were as follows:
 1 The possibility of the epileptogenic zone being located in deep 
areas in the cortex, specifically in limbic and paralimbic struc-
tures such as the mesial structures of the temporal lobe, cingu-
late gyrus, posterior orbitofrontal areas and insula
 2 The clinical impression that the epileptogenic zone had a more 
widespread location in the cortex, corresponding to a more dif-
fuse epileptogenic zone, indicated the need for a better map-
ping of the epileptogenic network
 3 Previous subdural invasive study and/or previous multiple op-
erations
 4 The need for bilateral implantation
 Planning and Procedure 
 The SEEG methodology implies a rigorous preimplantation in-
quiry of all available findings obtained during the noninvasive 
phase of investigation in order to define a coherent hypothesis of 
the anatomical localization of the epileptogenic zone. In this deci-
sion-making process, the respective significance of presurgical 
evaluation testing may vary greatly, depending on each patient. 
After a localizing hypothesis is formulated, a tailored implantation 
strategy is planned, with the goal of confirming or rejecting the 
preimplantation hypothesis. In this phase, the exploration is fo-
cused to sample the anatomic lesion (if present) and to determine 
the more likely structure(s) of ictal onset and the possible path-
way(s) of propagation of the seizures. The desired targets are 
reached using commercially available depth electrodes (AdTech, 
Racine, Wis., USA; Integra, Plainsboro, N.J., USA) implanted us-
ing a conventional stereotactic technique through 2.5-mm drill 
holes. Depth electrodes are implanted using orthogonal or oblique 
orientation, allowing intracranial recording from lateral, interme-
diate or deep cortical and subcortical structures in a three-dimen-
sional (3D) arrangement, thus accounting for the dynamic, multi-
directional spatiotemporal organization of the epileptic seizures. 
 As part of our routine practice, the patient is admitted to hos-
pital on the day of surgery. The day before surgery, a stereotactic 
contrast-enhanced volumetric T1 sequence MRI is performed. Im-
ages are then transferred to our stereotactic neuronavigation soft-
ware (iPlan Cranial 2.6; Brainlab AG, Feldkirchen, Germany) 
where trajectories are calculated the following day. On the day of 
surgery, while the patient is under general anesthesia, the Leksell 
stereotactic frame (Elekta, Sweden) is applied using the standard 
technique. Once the patient’s head is attached to the angiography 
table a noncontrast C-arm CT and a contrast-enhanced, subtract-
ed C-arm CT are performed. The injection protocol for the sub-
tracted C-arm CT used a prolonged X-ray delay of about 9 s to 
allow the visualization of both the arterial and the venous system 
in the resulting 3D images. The noncontrast C-arm CT images in-
cluding the N-fiducial box are sent to the neuronavigation soft-
ware for localization of the N-fiducial markers and for 3D registra-
tion with the MRI data set. The preoperative MR images and the 
contrast-enhanced C-arm CT images are then digitally processed 
using dedicated fusion software (syngo XWP; Siemens Healthcare, 
Forchheim, Germany). These fused images are overlaid on live flu-
oroscopic images and used during the time of implantation to con-
firm the accuracy of the final entry point of each electrode and to 
ensure the absence of vascular structures along the electrode path-
way (which were not previously noted with the contrasted MRI). 
After planning with the stereotactic software, trajectory coordi-
nates are recorded and transported to the operating room. Trajec-
tories are in general planned in orthogonal orientation in relation 
to the skull’s sagittal plane in order to facilitate implantation and 
later interpretation of the electrodes positions. In a few trajectories, 
electrodes are implanted in nonorthogonal trajectories, with the 
entry point closer to the vertex. Targets for nonorthogonal trajec-
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tories include the posterior orbitofrontal cortex, superior frontal 
gyrus and superior parietal lobule. The coordinates for each trajec-
tory are then adjusted in the stereotactic frame and a fluoroscopic 
image, in lateral view, is performed in each new position. Care is 
taken to ensure that the central beam of the fluoroscopic system is 
centered at the middle of the implantation probe to guarantee that 
the 3D image of the vasculature overlaid onto the live fluoroscop-
ic image is not distorted due to parallax effects. If a vessel is rec-
ognized along the pathway during fluoroscopy, the implantation 
probe is manually moved a few millimeters until the next avascular 
space is recognized. If the implantation probe is aligned correctly, 
corresponding to the planned trajectory and passing along an avas-
cular space, the implantation is then performed, with skull perfo-
ration, dura opening, placement of the guiding bolt and placement 
of the electrode under fluoroscopic guidance. The implantation 
progress is observed under fluoroscopic control in a frontal view 
to confirm the straight trajectory of each electrode. For additional 
guidance a coronal MRI slice corresponding to the level of each 
electrode implantation is overlaid onto the fluoroscopic image.
 A C-arm CT control scan is performed after each SEEG elec-
trode implantation. The reconstructed images are then fused with 
the MRI data set using the previously described fusion software. 
The resulting merged data sets are displayed and reviewed in axial, 
sagittal and coronal planes, allowing the verification of the correct 
placement of the electrodes.
 The SEEG electrodes remain for several days (on average 7 
days) for presurgical evaluation. After the presurgical evaluation 
and removal of the electrodes, a regular noncontrast CT is per-
formed in every patient. The integrity of the removed electrodes is 
confirmed.
 Implantation Accuracy Analysis 
 Postoperative analysis was performed by two ‘blind’ investiga-
tors (M.J.M. and M.v.R.) who had no information about the intra-
operative changes in the trajectory due to the presence of vascular 
structures. The data analysis was performed using 3D software 
(syngo InSpace) on a dedicated 3D workstation (syngo XWP; Sie-
mens Healthcare). 
 The following data sets were used for the postoperative analy-
sis:
 • MRI images (data set 1) 
 • Noncontrast C-arm CT images with the fiducial box (data set 2) 
 • 3D DSA C-arm CT images (data set 3) with corresponding 
mask images (data set 4) 
 • Noncontrast C-arm CT images with the implanted electrodes 
(data set 5) 
 • Control postimplantation CT images for hemorrhage detec-
tion acquired after the removal of electrodes (data set 6) 
 • List with coordinates of planned electrode trajectories from the 
stereotactic planning software (Brainlab system; data set 7) 
a
(For figure 1b see next page.)
Fig. 1.  a ,  b Fusion of data sets 1, 3 and 5 
with data set 2 making the aligned mea-
surement grid of data set 2 available in 
these data sets.
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 As a first step, a measurement grid was aligned within data set 
2 (noncontrast C-arm CT images with the fiducial box) to repre-
sent the coordinate system of the stereotactic frame defined by the 
N-fiducials of the fiducial box. Data sets 1, 3 and 5 (MRI images, 
3D DSA C-arm CT images, noncontrast C-arm CT images with 
the implanted electrodes) were fused with data set 2 to make the 
aligned measurement grid of data set 2 available in these data sets 
( fig. 1 a, b). Based on the measurement grid applied to data set 5 the 
coordinates of the entry points of the implanted electrodes were 
documented ( fig.  2 ) and compared to the original implantation 
plan ( fig. 3 ). The average difference in distance of the planned en-
try point versus the actual entry point (in x, y and z orientations) 
was recorded and analyzed.
 In terms of accuracy, the stereotactic y and z coordinates of the 
actual entry point for each electrode were identified. These coor-
dinates were recorded in the Excel file containing the preoperative 
intended x, y and z coordinates. The distance D between the 
planned and actual entry points was now calculated according to 
the formula: 
	 
 	 
2 2 .act plan act planD y y x x   
 Electrodes with Modified Trajectories 
 Trajectories with a distance greater than 3 mm between the 
planned entry point and the actual entry point were considered to 
be modified trajectories due to the presence of vascular structures 
along the planned trajectory during the implantation (information 
provided by the live overlay of the intraoperative CCTA). Modified 
trajectories were later confirmed by the senior author (J.G.-M.). 
For these electrode trajectories, further analyses were performed 
to characterize the presence or not of vascular structures along the 
trajectory:
 • The planned and actual coordinates of dura entry and target 
point as well as the corresponding trajectories were marked 
both in data set 1 (MRI) and data set 3 (subtracted C-arm 
CT) 
 • The marked trajectories were then visually checked for inter-
ferences with any vessel 
 Part II: Complication Rate 
 Hemorrhagic complications were prospectively collected and 
analyzed. Eighty-seven consecutive patients were studied, includ-
ing the 12 patients studied for the accuracy measurement. In total, 
1,310 electrodes were implanted and complications were analyzed 
by recording the hemorrhagic events observed in the immediate 
postoperative CT scans.
b
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 Results 
 Part I: Accuracy 
 As mentioned in Methods, 12 consecutive patients 
were studied with a total of 146 electrode trajectories an-
alyzed. The 12 patients included 7 females and 5 males, 
ranging in age from 24 to 43 years. All patients had refrac-
tory focal epilepsy with an indication for extraoperative 
invasive monitoring in order to further anatomically de-
fine the location of the epileptogenic zone. Fifty elec-
trodes were located on the left and 96 on the right. Elec-
trode locations were as follows: frontal (n = 47), mesial 
temporal (hippocampal, n = 10), insular (n = 6), parietal 
(n = 43), lateral temporal (n = 30) and occipital (n = 10). 
No severe adverse event, such as hemorrhagic or infective 
complications, was seen in this study group. No compli-
cations were associated with the CCTA procedures.
 The mean accuracy was 0.88 ± 0.92 mm (range 0–2.9) 
for the electrodes which were implanted as preoperative-
ly intended. Readjustment of the entry point of the elec-
trodes was performed for 27 electrode trajectories (18%) 
according to the additional information gained by direct 
intraoperative CCTA and confirmed by the operating 
neurosurgeon (J.G.-M.). In the modified trajectory group 
(27 in total), 15 trajectories were located in the frontal 
lobe, 10 in the temporal lobe and 2 in the parietal lobe. In 
6 trajectories, both the intended and the modified trajec-
tory had some minor interference with the vasculature, 
but no clear vessel/electrode collision. No interference 
with the vasculature was evident for 2 of the electrodes. 
In 10 electrodes, the intended trajectory (based on con-
trast-enhanced MRI images only), but not the actual tra-
jectory (corrected after the analysis with the digitally 
fused 3D DSA C-arm CT images), would have had serious 
interference with the vasculature.
 Part II: Complication Rate and Seizure Outcome 
 The review of postinterventional CT of the 87 con-
secutive patients (42 males and 45 females, mean age of 
35 years) implanted with 1,310 SEEG electrodes showed 
 Fig. 2. Analysis of the actual entry points 
based on the measurement grid applied to 
data set 5. 
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1 intracerebral hemorrhagic contusion ( fig. 4 ). No com-
plications due to the angiographic procedure were ob-
served. The cerebral hemorrhagic contusion was located 
in the mesial frontal lobe cortex (leg area in the Rolandic 
cortex), causing transitory leg weakness which recovered 
after 15 days with no residual deficits. Repeated CT at 
this time revealed a complete resolution of the contu-
sional area. None of the 146 electrode trajectories ana-
lyzed in part I resulted in hemorrhagic complications. 
For the entire studied group (87 patients – 1,310 implant-
ed electrodes), the rate of hemorrhagic complications/
implanted electrodes was 0.07%. In the retrospective 
analysis of the 87 patients, 65 patients underwent resec-
tions (75%). From this group, 62% remained seizure free 
after 1 year. 
 Discussion 
 The use of angiograms for SEEG implantation is con-
troversial. Respecting the cerebral vasculature of each in-
dividual patient is of paramount importance to ensure the 
safety of SEEG implantation. Therefore, advanced imag-
ing modalities like cerebral angiography, CT and con-
trast-enhanced MRI have been used  [12, 19–23, 25, 26] . 
Although the use of CCTA is not new in SEEG, its utility 
in avoiding vascular injury has never been demonstrated. 
Our results support previous concepts that the use of 
CCTA in association with other imaging modalities may 
drastically diminish the incidence of vascular injuries in 
SEEG procedures. 
 According to the results of this recent investigation 
and previous publications, no single vascular imaging 
modality provides 100% safety for the implantation of 
SEEG  [12, 19–23, 25, 26] . While others have advocated 
MRI to be sufficient for preoperative planning  [24, 27] , 
we observed an additional benefit of intraoperative 
CCTA, refining the final electrode position in order to 
avoid collision with vascular structures, preventing po-
tential devastating complications. In our series, 18% of 
the trajectories, which had previously been planned us-
ing contrast-enhanced MRI only, were modified after us-
ing the intraoperative CCTA as an overlay on the live 
fluoroscopic image. Conversely, in 6 trajectories with po-
tential vascular collisions on the intended and actual tra-
jectories, no hemorrhagic events were observed. In this 
clinical scenario, we can speculate that it is quite possible 
that even with eminent vascular collisions, vessels may 
shift away from the electrodes, preventing vascular in-
jury. 
 Fig. 3. 3D angiographic reconstruction (lateral view) showing the 
intended SEEG electrode trajectory (yellow), with clear vascular 
collision and the moved (blue) trajectory, now through an avascu-
lar space. 
 Fig. 4. CT scan of the only hemorrhagic complication among the 
1,130 implanted SEEG. 
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 It is important to emphasize that these 6 trajectories 
were all located in the perisylvian/insular areas where ar-
teries are generally located within large cisternal spaces 
and, despite the maximal effort to avoid such collisions, 
the clinical necessity to explore these cortical areas over-
came the risks of possible hemorrhagic events. Based on 
this discussion, we can argue that an electrode-vessel col-
lision on the matched images (preimplantation DSA and 
postoperative CT) is not reliable to prove a real collision. 
This assumption is further supported by our results, as we 
had no intra-axial bleeding on postoperative CT despite 
the predictable electrode-vessel collision on the fused im-
ages. The most reasonable explanation might be the mo-
bility of the vessels, as they become mechanically dis-
placed rather than penetrated by the inserting electrode. 
This is mostly true in arterial vessels rather than veins due 
to the fact that arteries are located in cisternal spaces, al-
lowing a certain degree of mobility, unlike veins, which 
are attached to the brain, with very limited movement. 
Despite the possibility of vascular dislodgement in par-
ticular areas, the use of the CCTA allowed us to perform 
more aggressive and extensive exploration, especially in 
areas surrounded by an intense vascular network, such as 
the insula, perisylvian cortex and posterior orbitofrontal 
area. 
 The safety and usefulness of our approach was also 
confirmed by the fact that only 1 electrode caused a symp-
tomatic contusion among the 1,310 inserted electrodes 
and no clear hematomas were observed in the entire se-
ries. Although the relatively large experience with SEEG 
implantation at the Cleveland Clinic Epilepsy Center 
confirms a very low risk for vascular injury using the cur-
rent method of implantation, a residual risk may remain 
unavoidable. While the presented risk of vascular injury 
seems to be negligible in most experienced hands per-
forming this procedure almost daily, these results may 
not reflect the general outcome at every center, and cau-
tion has to be practiced.
 Several authors have reported acceptable complica-
tion rates without the angiogram but with the use of oth-
er vascular imaging modalities, such as double-dose gad-
olinium-contrasted MRIs, where vessels can be clearly 
visualized and electrode trajectories can be planned ac-
cordingly  [28, 29] . Nevertheless, when reviewing the lit-
erature, the rate of complications using MRI only (with-
out angiogram) tends to be higher than with the angio-
gram. De Almeida at al.  [22] , using the MRI technique 
only, reported a rate of hemorrhagic complication to be 
almost 3 times higher (0.7% per electrode) compared to 
other groups using the angiographic technique. It is like-
ly that for the higher complication rates reported, espe-
cially in extratemporal implantations in surgical series 
utilizing the MRI technique only, the implantations 
tended to be less aggressive, with few electrodes implant-
ed in the insula or frontal/Rolandic areas and more elec-
trodes implanted in the temporal areas. In addition, the 
double-dose gadolinium technique, a possible alterna-
tive to the angiographic technique, is problematic, being 
associated with renal complications due to surpassing 
the maximal dose considered to be safe. Although our 
opinion favors the use of the cerebral angiogram, further 
studies are necessary to clarify the utility of this tech-
nique in preventing vascular complications in SEEG pro-
cedures.
 Since its conceptualization, the SEEG technique has 
been closely associated with the use of the cerebral angio-
gram. However, Talairach and Bancaud  [13] had to oper-
ate on 0.5% of their patients because of severe intracere-
bral hematoma following SEEG implantation. However, 
this series was from the pre-CT era and we can possibly 
speculate that the real incidence of hemorrhagic compli-
cations could have been even higher. Later, a study pub-
lished by Espinosa et al.  [25] described a risk of subdural 
hematoma in 0.6% of their patients and Engel et al.  [29] 
even described a mortality rate of 1.4% with the place-
ment of depth electrodes. Also, Guenot et al.  [19] report-
ed 1 death due to intracranial hematoma. Conversely, in 
a large SEEG series, Cossu et al.  [20] had serious hemor-
rhagic complication in 9 (4.2%) of their patients with a 
need for emergency surgical evacuation in 3 patients, de-
spite the use of cerebral angiogram. Although the meth-
odology used by Cossu et al.  [20] is quite similar to the 
described method, the cerebral angiogram was used in 
the preimplantation planning and not during the intra-
operative procedure, perhaps contributing to fewer intra-
cranial bleedings. Nevertheless, a fair comparison in 
terms of morbidity cannot be completely performed since 
size and demographical characteristics are quite different 
in both series.
 Conclusion 
 In addition to contrast-enhanced MRI, SEEG-im-
planted patients benefit from intraoperative cerebral 
CCTA during the insertion of intracranial depth elec-
trodes. The proposed combined approach drastically 
minimizes the risk of hemorrhagic complications, allow-
ing more aggressive implantation in more vascularized 
cortical areas.
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